Results of more studies testing the SGLT-2 inhibitor sotagliflozin in people with type 1 diabetes, continued to be encouraging: Sotagliflozin reduced A1C and body weight, lowered insulin doses, and caused fewer episodes of severe hypoglycemia compared to control groups
This will support development of a dynamic model linking FXN deficiency, ironsulfur cluster disruption, and mitochondrial ferroptosis and help identify organ-specific drivers
Important Considerations Before Starting GLP-1 Medications If you or someone you know is considering GLP-1 medications, several important factors deserve careful thought
Hims & Hers sells compounded semaglutide for less than $200 per month, while Ozempic and Wegovy both cost around $1,000 per month without insurance
Stand-Alone Options: Lumen Device : $399, including AI food log and nutrition coaching
What "peptides" actually covers If muscle preservation, body composition, or repair and recovery are the problem you're solving, you're likely looking at a different part of the peptide category one that has nothing to do with appetite suppression
